Orbit International Corp (ORBT) 3.6300 $ORBT Orbit

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Orbit International Corp (ORBT) 3.6300 $ORBT

Orbit International's Electronics Group Receives Orders in Excess of $1,000,000 for Month of May
Marketwire Canada - Tue Jun 07, 7:45AM CDT
HAUPPAUGE, NY--(Marketwired - Jun 7, 2016) - Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solution provider, today announced that bookings for its Electronics Group exceeded $1,000,000 for the month of May 2016. 

Orbit International Corp. Reports 2016 First Quarter Results
Marketwired - Thu May 05, 7:45AM CDT
First Quarter Net Income $35,000 ($.01 per Share) v. Loss of $326,000 in Prior Year Quarter ($.07 loss per Share)

Orbit International Consolidated Bookings Exceed $9,000,000 for First Quarter of 2016
Marketwired - Wed Apr 06, 7:45AM CDT
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solution provider, today announced that consolidated bookings for both its Electronics and Power Groups exceeded $9,000,000 for the three months ended March 31, 2016.

Orbit International Receives Orders in Excess of $2,800,000 for Month of February
Marketwired - Thu Mar 03, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solution provider, today announced that consolidated bookings for both its Electronics and Power Groups exceeded $2,800,000 for the month of February 2016.

Orbit International's Electronics Group Receives Three Follow-On Production Orders Totaling in Excess of $1,600,000
Marketwired - Tue Feb 09, 7:45AM CST
Orbit International Corp. (PINKSHEETS: ORBT), an electronics manufacturer and software solutions provider, today announced that its Electronics Group has received three new follow-on production orders for its switch panels and keyboards valued in excess of $1,600,000. Deliveries are expected to commence in the third quarter of 2016 and continue through the first quarter of 2017.

Orbit International Receives Orders in Excess of $4,650,000 for Month of January
Marketwired - Wed Feb 03, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solution provider, today announced that consolidated bookings for both its Electronics and Power Groups exceeded $4,650,000 for the month of January 2016.

Orbit International's Electronics Group Receives Production Order in Excess of $1,050,000
Marketwired - Tue Jan 26, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solutions provider, today announced that its Electronics Group has received a new production order for its switch panels on an aviation program valued in excess of $1,050,000. Deliveries are expected to commence in the third quarter of 2016 and continue through the first quarter of 2017.

Orbit International's Electronics Group Receives Three New Orders Totaling in Excess of $1,300,000
Marketwired - Fri Dec 18, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solutions provider, today announced that its Electronics Group, has recently received three new orders for its displays, switch panels and keyboards totaling in excess of $1,300,000. Deliveries are expected to commence in the second quarter of 2016 and continue through the fourth quarter of 2016.

Orbit International Receives Orders in Excess of $3,000,000 for Month of November
Marketwired - Thu Dec 03, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solution provider, today announced that consolidated bookings for both its Electronics and Power Groups exceeded $3,000,000 for the month of November.

Orbit International's Power Group Receives New Order Totaling in Excess of $1,870,000
Marketwired - Wed Nov 18, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solutions provider, today announced that its Power Group, through its Behlman Electronics, Inc. subsidiary ("Behlman", has received a new order for a power supply valued in excess of $1,870,000 for its COTS division.

Orbit International Corp. Reports 2015 Third Quarter Results
Marketwired - Thu Nov 05, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT) today announced results for the third quarter and nine months ended September 30, 2015.

Orbit International's Power Group Receives New Order Valued at Approximately $770,000 for Its COTS Division
Marketwired - Wed Jun 03, 7:45AM CDT
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solutions provider, today announced that its Power Group, through its Behlman Electronics, Inc. subsidiary ("Behlman", recorded total bookings for the month of May in excess of $1,000,000. These total bookings were highlighted by a new order valued at approximately $770,000 for its COTS division.

Orbit International's Electronics Group Receives New Orders in April Totaling Over $1,000,000
Marketwired - Tue May 05, 7:45AM CDT
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solution provider, today announced that its Electronics Group received new and follow-on orders for its products on several programs in the month of April totaling over $1,000,000.

Orbit International's First Quarter Bookings Exceed $6,000,000 for Third Consecutive Quarter
Marketwired - Tue Apr 07, 7:45AM CDT
Orbit International Corp. (PINKSHEETS: ORBT), an electronics manufacturer and software solution provider, today announced that consolidated bookings for its Electronics and Power Groups exceeded $6,000,000 for the first quarter of 2015, the third consecutive quarter that bookings have exceeded this level.

Orbit International's Power Group Receives New Orders Totaling in Excess of $1,000,000
Marketwired - Thu Feb 05, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solutions provider, today announced that its Power Group, through its Behlman Electronics, Inc. subsidiary ("Behlman", has received new orders for power supplies and backplanes valued in excess of $1,000,000.

Orbit International's Electronics Group Receives New Order in Excess of $2,000,000
Marketwired - Thu Jan 29, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solution provider, today announced that its Electronics Group received an order in excess of $2,000,000 for a follow-on order for human machine interface (HMI) applications it has been providing to the U.S. Navy.

Orbit International's Power Group Receives New Orders Valued in Excess of $1,675,000 for Its COTS Division
Marketwired - Tue Jan 06, 7:45AM CST
Orbit International Corp. (OTC PINK: ORBT), an electronics manufacturer and software solutions provider, today announced that its Power Group, through its Behlman Electronics, Inc. subsidiary ("Behlman", has received two new orders valued in excess of $1,675,000 for its COTS division.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 17

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 311

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 35

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 68

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 0

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Preeclampsia: Key Insights for Expecting Parents

Updated Category News Views 46

Preeclampsia: Essential Insights for Expecting Parents Preeclampsia is a significant condition that often raises concerns among expecting parents. It manifests as a dangerous form of high blood pressure during pregnancy and can also surface postpartum. Understanding this condition is vital for ensuring the health and safety of both mother and child during this crucial...

Continue Reading
DTE Energy Enhances Reliability with Smart Grid Technology

Updated Category News Views 240

DTE Energy's Progress with Smart Grid Technology DTE Energy (NYSE:DTE) has announced impressive strides in enhancing energy reliability through its cutting-edge smart grid technology. This initiative has successfully prevented nearly 5,000 power interruptions and saved over 1.8 million outage minutes for customers this year, highlighting the technology's role in ensuring...

Continue Reading
Key Insider Transactions in Major US Companies Unveiled

Updated Category News Views 270

Significant Insider Trading Activities This article sheds light on the notable insider buying and selling events reported recently, reflecting the movements within major US stocks. Major Insider Purchases Berkshire Hathaway Inc. (NYSE: BRKa) has made headlines by increasing its stake in Verisign Inc. (NASDAQ: VRSN). Under the leadership of Warren E. Buffett, the company...

Continue Reading
Hull Tactical's Latest Research Paper Enhances Market Predictions

Updated Category News Views 135

Hull Tactical Releases Innovative Academic Research The Hull Tactical team is excited to unveil its latest academic paper, titled Micro Alphas, co-authored by a talented group including Blair Hull, Petra Bakosova, Francois Cocquemas, Euan Sinclair, and Petri Fast. This research introduces a fresh framework that focuses on utilizing weak yet collectively informative...

Continue Reading
Cyrano Therapeutics and KYORIN Join Forces for Smell Loss Treatment

Updated Category News Views 138

Cyrano Therapeutics and KYORIN Collaboration Overview Cyrano Therapeutics, a pioneer in regenerative medicine, has taken a significant step forward in addressing the challenge of post-viral loss of smell. The company has entered into an option agreement with KYORIN Pharmaceutical Co., Ltd. to develop CYR-064, a promising treatment candidate specifically designed for those...

Continue Reading